UDTR Global Radar

UDTR Global Rights of Nature Radar

Documentary registry of records detected across the scholarly, legal and institutional infrastructures monitored by UDTR.

A global documentary infrastructure designed to achieve the broadest verifiable and scientifically defensible coverage of the Rights of Nature.

← Back to Radar

Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum

Identification

Public canonical key
radar:r-08e7650e9c34d89d82d0e9036eaa0190
Authors
Baixun He · Jie Fu · Chong Chen · Wenxin Zhang · Shuang Li · Cherie S. Tan · Dong Ming
Reported year
2025
Reported language
en
Source type
article
First detected
2026-11-14T02:03:29.550623+00:00
Last metadata observation
2026-11-14T02:03:29.550623+00:00
Last HTTP verification
Not checked

Institutions reported by the source

Tianjin University · Nankai University · Tianjin Medical University Cancer Institute and Hospital

Reported affiliation countries

CN

Documentary abstract — original language

The target neutrophil-activating peptide-2, NAP2, is a potential biomarker for early lung cancer diagnosis, whereas there are currently no precise techniques for differentiating NAP2 from its precursors. To overcome this difficulty, we created an electrochemical aptamer-based sensor (E-AB) consisting of the 33-mer aptamer domain, a 2-bp three-junction region, and two conductive signal reporter stems. Whereas E-AB-AT and E-AB-RAN sensors with two (AT) 6 or N 12 stems, respectively, were unable to distinguish between platelet basic protein (PBP) (94 aa) and NAP2 (70 aa). However, in contrast, the E-AB-GC sensor with two (GC) 6 stems could selectively detect NAP2 but hardly recorded PBP. Here, we developed an E-AB-GC point-of-care test (POCT) technique to detect NAP2 away from its precursors in 10 μL of human serum and provide concentration data in 5 min. Interestingly, serum NAP2 levels in human samples, as determined by the E-AB-GC sensor, were roughly 30–50% lower than those obtained by ELISA. Results also showed that E-AB-GC analysis of serum NAP2 in patients in stages I through IV revealed statistical significance and an excellent guiding function in the early diagnosis of lung cancer, particularly for patients in stage I cancer ( p = 0.0054, area under the curve, 0.95). Importantly, this E-AB-GC POCT platform has shown potential as an on-site quick diagnostic tool, which can also be used to detect other lung cancer markers. Our research on the impacts of stem sequencing on sensing capabilities might assist in the future development of E-AB biomarker sensors.

Identifiers

OPENALEX
https://openalex.org/W4409381364
DOI
10.1021/acs.analchem.4c06815
PMID
https://pubmed.ncbi.nlm.nih.gov/40215095

Documentary context

Documentary family
article
Source-reported types
article
Publishers
American Chemical Society

Entity mentions are not evidence of legal recognition. Jurisdiction studied is separate from author affiliation country.

Sources

OpenAlex · Record 1

Cite this reference

Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. 2025. https://doi.org/10.1021/acs.analchem.4c06815

JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·

APA, Chicago, ISO 690: bibliographic formats using available fields. OSCOLA / Bluebook: structured data only; full legal citation compliance is not claimed without verification of required elements.

APA
Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. (2025). Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. https://doi.org/10.1021/acs.analchem.4c06815
Chicago
Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. 2025. https://doi.org/10.1021/acs.analchem.4c06815
ISO 690
Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. 2025. https://doi.org/10.1021/acs.analchem.4c06815

Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31

UDTR Global Rights of Nature Legal Library. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. Documentary record: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-08e7650e9c34d89d82d0e9036eaa0190/ · Last HTTP verification: not performed

Report a correction

Frozen-version metadata

Research dossiers and documentary relations

Source roles

Bibliographic / original publication source · https://doi.org/10.1021/acs.analchem.4c06815

An authority link alone does not verify a legal claim. Abstracts and full texts remain subject to their source terms.

Documentary status

Relevance pending

Library

This identity is not yet included in the Legal Library.

UDTR Global Rights of Nature Legal Library